04.02.2025 14:56:11
|
Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market
(RTTNews) - Pulse Biosciences, Inc. (PLSE), a novel bioelectric medicine company, Tuesday announced the appointment of Jon Skinner as Chief Financial Officer, with effect from February 3.
Shares of Pulse Biosciences are increasing by 6% in the pre-market trading.
Skinner most recently served as Vice President, FP&A and Investor Relations at Copeland
In the pre-market trading, Pulse Biosciences is 5.20% higher at $21.45 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pulse Biosciences Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Pulse Biosciences Incmehr Analysen
Aktien in diesem Artikel
Pulse Biosciences Inc | 15,70 | 2,61% |
|